1[1]Koh THHG, Eyre JA, Aynsley - Green A. Neural dysfunction during hypoglycaemia. Arch Dis Child, 1988, 63:1386 -1389.
2[2]Lucas A, Morley R, Cole TF. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ, 1998,297:1304- 1308.
3[3]Comblath M, Schwartz R, Aynsley- Green A. Hypoglycemia in infancy: The need for rational definition. Pediatrics, 1990,85: 834 - 837.
4[4]Rennie JM, et al. Textbook of Neonatology. ed3. London:Churchill Livingstone 1999,944 - 949.
5[5]Friberg H, Ferrand-Drake M, Bengtsson F, et al. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci, 1998, 18:5151-5159.
7[7]Barkovich AJ, Ali FA, Rowley HA, et al. Imaging patterns of neonatal hypnglycemia. Am J Neuroradiol, 1998, 19:523 -528.
8[8]Chiu NT, Huang CC, Chang YC, et al. Technetium- 99mHMPAO brain SPECT in neonates with hypoglycemic enecphalopathy. J Nucl Med, 1998,39:1711 - 1713.
9[9]De - Courten- Myers GM, Xi G, Hwang JH, et al. Hypoglycemic brain injury: potentiation from respiratory depression and injury aggravation from hyperglycemic treatment overshoots. J Cereb Blood Flow Metab, 2000,20:82-92.
10[10]Kaya M, Kucuk M, Kalayci RB, et al. Magnesium sulfate attenuates increased blood - brain barrier permeability during insulin - induced hypoglycemia in rats. Can J Physiol Pharmacol,2001,79:793 - 798.
